Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLOVER BIO-B

0.475
-0.005-1.04%
Volume:13.81M
Turnover:6.48M
Market Cap:616.08M
PE:-0.60
High:0.510
Open:0.490
Low:0.440
Close:0.480
Loading ...

Clover Biopharmaceuticals Ltd. Conducted Annual General Meeting

Reuters
·
19 Jun

Clover Initiates Phase I Clinical Trial for Rsv + Hmpv ± Piv3 Respiratory Combination Vaccine Candidates

THOMSON REUTERS
·
17 Jun

Clover Biopharmaceuticals Ltd. Initiates Phase I Clinical Trial for Novel Respiratory Combination Vaccine Candidates

Reuters
·
17 Jun

Clover Biopharmaceuticals Terminates Distribution Agreement with Adimmune

Reuters
·
16 Jun

Clover Biopharmaceuticals Ltd - Termination of Cooperation With Adimmune

THOMSON REUTERS
·
16 Jun

Clover Biopharmaceuticals Ltd. Faces Arbitration Request from Gavi Over Advance Payment Dispute

Reuters
·
09 Jun

Clover Biopharmaceuticals Ltd - Gavi Files Arbitration Request Against Clover HK for Repayment

THOMSON REUTERS
·
09 Jun

Clover Biopharmaceuticals Ltd - Continues Development of Rsv Vaccine Candidate Scb-1019

THOMSON REUTERS
·
09 Jun

Clover Biopharmaceuticals Announces Auditor Change: EY Retires, CL Partners Proposed

Reuters
·
19 May

BRIEF-Clover Biopharmaceuticals Posts Loss For Year RMB903.4 Million

Reuters
·
31 Mar

Clover Biopharmaceuticals Ltd - FY Revenue RMB38.4 Mln

THOMSON REUTERS
·
31 Mar

Clover Biopharmaceuticals Begins US Trial for RSV Vaccine SCB-1019

MT Newswires Live
·
24 Mar

BRIEF-Clover Biopharmaceuticals Says Gavi Terminates Advance Purchase Agreement With Clover HK

Reuters
·
24 Mar

BRIEF-Clover Biopharmaceuticals Reports Clearance Of Study For Rsv Vaccine Candidate By FDA

Reuters
·
24 Mar

Clover Announces U.S. Ind Clearance and Initiation of Revaccination Clinical Study for Rsv Vaccine Candidate Scb-1019

THOMSON REUTERS
·
24 Mar

Clover Biopharmaceuticals - Announces U.S. Ind Clearance and Initiation of Revaccination Clinical Study for Rsv Vaccine Candidate Scb-1019 by US FDA

THOMSON REUTERS
·
24 Mar

Clover Biopharmaceuticals - Gavi Terminates Advance Purchase Agreement With Clover HK

THOMSON REUTERS
·
24 Mar

Clover Biopharmaceuticals - Rejects Gavi Alliance's Claim for $224 Million Repayment

THOMSON REUTERS
·
24 Mar